Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 153,499 | 99,742 | 68,700 | 51,382 | 26,453 |
| Operating Income | -153,499 | -99,742 | -68,700 | -51,382 | -26,453 |
| Other Income | 1,938 | 224 | 1,737 | 3,885 | 2,202 |
| Pre-tax Income | -151,561 | -99,518 | -66,963 | -47,497 | -24,251 |
| Income Tax | 261 | 289 | 161 | 102 | N/A |
| Net Income Continuous | -151,822 | -99,807 | -67,124 | -47,599 | -24,251 |
| Net Income | $-151,822 | $-99,807 | $-67,124 | $-47,599 | $-24,251 |
| EPS Basic Total Ops | -3.93 | -2.63 | -2.40 | -4.62 | -98.53 |
| EPS Basic Continuous Ops | -3.93 | -2.63 | -2.40 | -2.26 | -38.82 |
| EPS Diluted Total Ops | -3.93 | -2.63 | -2.40 | -4.62 | -98.53 |
| EPS Diluted Continuous Ops | -3.93 | -2.63 | -2.40 | -2.26 | -38.82 |
| EPS Diluted Before Non-Recurring Items | -3.93 | -2.63 | -2.40 | -4.62 | -98.53 |
| EBITDA(a) | $-150,453 | $-96,915 | $-67,108 | $-50,520 | $-26,034 |